Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Biologically active versus immunoreactive high-mobility group box 1.

Alleva LM.

Crit Care Med. 2007 Jul;35(7):1809; author reply 1809. No abstract available.

PMID:
17581395
2.

High-mobility group box 1 (HMGB1) as a potential therapeutic target in sepsis--more questions than answers.

Waterer GW.

Crit Care Med. 2007 Apr;35(4):1205-6. No abstract available.

PMID:
17413792
3.

Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis.

Angus DC, Yang L, Kong L, Kellum JA, Delude RL, Tracey KJ, Weissfeld L; GenIMS Investigators.

Crit Care Med. 2007 Apr;35(4):1061-7.

PMID:
17334246
4.

Systemic and local high mobility group box 1 concentrations during severe infection.

van Zoelen MA, Laterre PF, van Veen SQ, van Till JW, Wittebole X, Bresser P, Tanck MW, Dugernier T, Ishizaka A, Boermeester MA, van der Poll T.

Crit Care Med. 2007 Dec;35(12):2799-804.

PMID:
17901841
5.

Association of high mobility group box-1 protein levels with sepsis and outcome of severely burned patients.

Huang LF, Yao YM, Dong N, Yu Y, He LX, Sheng ZY.

Cytokine. 2011 Jan;53(1):29-34. doi: 10.1016/j.cyto.2010.09.010. Epub 2010 Oct 25.

PMID:
20980161
6.

Severity of sepsis is correlated with the elevation of serum high-mobility group box 1 in rats.

Hou LC, Qin MZ, Zheng LN, Lu Y, Wang Q, Peng DR, Yu XP, Xin YC, Ji GL, Xiong LZ.

Chin Med J (Engl). 2009 Feb 20;122(4):449-54.

PMID:
19302753
7.

The effect of a novel cytokine, high mobility group box 1 protein, on the development of traumatic sepsis.

Yao YM, Sheng ZY, Huang LF.

Chin J Integr Med. 2009 Feb;15(1):13-5. doi: 10.1007/s11655-009-0013-0. Epub 2009 Mar 7. No abstract available.

PMID:
19271163
8.

Neutralization of receptor for advanced glycation end-products and high mobility group box-1 attenuates septic diaphragm dysfunction in rats with peritonitis.

Susa Y, Masuda Y, Imaizumi H, Namiki A.

Crit Care Med. 2009 Sep;37(9):2619-24. doi: 10.1097/CCM.0b013e3181a930f7.

PMID:
19623040
9.

Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma.

Cheng BQ, Jia CQ, Liu CT, Lu XF, Zhong N, Zhang ZL, Fan W, Li YQ.

Dig Liver Dis. 2008 Jun;40(6):446-52. doi: 10.1016/j.dld.2007.11.024. Epub 2008 Feb 21.

PMID:
18294942
10.
11.

Is there a role for high mobility group box 1 and the receptor for advanced glycation end products in the genesis of long-term cognitive impairment in sepsis survivors?

Dal-Pizzol F, Pasquali M, Quevedo J, Gelain DP, Moreira JC.

Mol Med. 2012 Dec 20;18:1357-8; author reply 1359. doi: 10.2119/molmed.2012.00317. No abstract available.

12.

Tolerization with BLP down-regulates HMGB1 a critical mediator of sepsis-related lethality.

Coffey JC, Wang JH, Kelly R, Romics L Jr, O'Callaghan A, Fiuza C, Redmond HP.

J Leukoc Biol. 2007 Oct;82(4):906-14. Epub 2007 Jul 11.

PMID:
17626148
13.

[Updated understanding of high mobility group box 1 protein in sepsis].

Yao YM, Liu H.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2005 Jul;17(7):385-7. Chinese. No abstract available.

14.

C-reactive protein induces high-mobility group box-1 protein release through activation of p38MAPK in macrophage RAW264.7 cells.

Kawahara K, Biswas KK, Unoshima M, Ito T, Kikuchi K, Morimoto Y, Iwata M, Tancharoen S, Oyama Y, Takenouchi K, Nawa Y, Arimura N, Jie MX, Shrestha B, Miura N, Shimizu T, Mera K, Arimura S, Taniguchi N, Iwasaka H, Takao S, Hashiguchi T, Maruyama I.

Cardiovasc Pathol. 2008 May-Jun;17(3):129-38. doi: 10.1016/j.carpath.2007.08.006. Epub 2007 Oct 24.

PMID:
18402807
15.

[Effect of ethyl pyruvate on renal high mobility group box-1 protein expression and acute kidney injury in rats with delayed resuscitation after thermal injury].

Wang Q, Yao YM, Wang YB, Wang WJ, Xian LM, Dou KF, Sheng ZY.

Zhonghua Wai Ke Za Zhi. 2007 Sep 1;45(17):1210-3. Chinese.

PMID:
18067720
16.

Bacterial endotoxin induces the release of high mobility group box 1 via the IFN-beta signaling pathway.

Kim JH, Kim SJ, Lee IS, Lee MS, Uematsu S, Akira S, Oh KI.

J Immunol. 2009 Feb 15;182(4):2458-66. doi: 10.4049/jimmunol.0801364.

17.

High mobility group box 1 (HMGB1) and macrophage migration inhibitory factor (MIF) in Kawasaki disease.

Hoshina T, Kusuhara K, Ikeda K, Mizuno Y, Saito M, Hara T.

Scand J Rheumatol. 2008 Nov-Dec;37(6):445-9. doi: 10.1080/03009740802144143.

PMID:
18720262
18.
19.

High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity.

Bianchi ME, Manfredi AA.

Immunol Rev. 2007 Dec;220:35-46. Review.

PMID:
17979838
20.

High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo.

Faraco G, Fossati S, Bianchi ME, Patrone M, Pedrazzi M, Sparatore B, Moroni F, Chiarugi A.

J Neurochem. 2007 Oct;103(2):590-603. Epub 2007 Jul 31.

Supplemental Content

Support Center